Krüger, A <br/><br/>
Hydroxamate-type matrix metalloproteinase inhibitor batimastat promotes liver metastasis.  [electronic resource] 

 -  Cancer research  Feb 2001 
 - 1272-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inducing Agents--biosynthesis<br/>Animals<br/>Antineoplastic Agents--toxicity<br/>Caspase 1--biosynthesis<br/>Female<br/>Humans<br/>Liver--drug effects<br/>Liver Neoplasms, Experimental--chemically induced<br/>Lung Neoplasms--chemically induced<br/>Lymphoma, T-Cell--enzymology<br/>Mammary Neoplasms, Experimental--enzymology<br/>Matrix Metalloproteinase 2--biosynthesis<br/>Matrix Metalloproteinase 9--biosynthesis<br/>Matrix Metalloproteinase Inhibitors<br/>Mice<br/>Mice, Inbred DBA<br/>Mice, Nude<br/>Neoplasm Transplantation<br/>Oligonucleotide Array Sequence Analysis<br/>Phenylalanine--analogs & derivatives<br/>Protease Inhibitors--toxicity<br/>RNA, Messenger--biosynthesis<br/>Thiophenes--toxicity<br/>Up-Regulation--drug effects